QINGHUI LIANNUO
Qinghui Liannuo is a scientific and technological innovation enterprise that transforms Tsinghua University's achievements in the research and development and application of immunotherapy technology. Actively promote the development of the γδ-T cell immunotherapy industry. Committed to bringing good news to patients with refractory and recurrent solid tumors and hematomas.
QINGHUI LIANNUO
Industry:
Biotechnology Health Care Life Science Medical Pharmaceutical
Founded:
2018-09-01
Address:
Beijing, Beijing, China
Country:
China
Website Url:
http://www.unicetbio.com
Total Employee:
11+
Status:
Active
Contact:
+86 13070108016
Email Addresses:
[email protected]
Total Funding:
100 M CNY
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Content Delivery Network Mobile Non Scaleable Content Nginx DigiCert SSL Encryption Everywhere Alibaba Bootcss
Similar Organizations
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Dauntless Pharmaceuticals
Dauntless Pharmaceuticals is a biotechnology company that focuses on the development of drugs.
Huasaiboman Medical Cell Biology
Huasaiboman Medical Cell Biology is a biotechnology company engaged in providing new cell therapy technologies and solutions.
Lyotropic Delivery System
LDS is a privately owned nano and biotechnology company that focuses on the development of novel liquid nano-sized delivery vehicles.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Seismic Therapeutic
Seismic Therapeutic is a biotechnology company advancing machine learning for immunology drug development.
Investors List
Highlight Capital
Highlight Capital investment in Seed Round - Qinghui Liannuo
Official Site Inspections
http://www.unicetbio.com
- Host name: 47.242.244.68
- IP address: 47.242.244.68
- Location: San Mateo United States
- Latitude: 37.5517
- Longitude: -122.33
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94402
More informations about "Qinghui Liannuo"
Qinghui Liannuo - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +86 13070108016 Qinghui Liannuo is a scientific and technological innovation enterprise that transforms Tsinghua University's …See details»
Beijing Qinghui Liannuo Biotechnology Co Ltd. - Drug pipelines, …
Www.unicetbio.com. Last update 01 Nov 2024. Overview. Pipeline. Deal. Translational Medicine. Profit. Grant & Funding(NIH) Investment. Financing. Overview. Related. 100 Clinical Results …See details»
Beijing Qinghui Liannuo Biotechnology Co Ltd. (Beijing Qinghui …
了解Beijing Qinghui Liannuo Biotechnology Co Ltd. (Beijing Qinghui Liannuo Biotechnology Co Ltd.)公司的药物管线，治疗领域，技术平台，以及它的。See details»
Beijing Unicet Biotechnology - PitchBook
Beijing Unicet Biotechnology General Information Description. Developer of cell therapy system. The company aims to transform excellent research results into clinical applications, and has …See details»
北京清辉联诺生物科技有限责任公司 - 企查查
Sep 26, 2018 简介： 北京清辉联诺生物科技有限责任公司是⼀家成⽴于2018年09月26日的其他有限责任公司，属于以从事科学研究和技术服务业为主的企业。 位于北京市昌平区，法定代 …See details»
清辉联诺 | 项目信息-36氪
May 14, 2023 清辉联诺（Unicet Biotech）由清华大学药学院张永辉教授领衔创立。张永辉教授一直致力于研究代谢对免疫的调控机制，探索新型免疫治疗策略，相关研究成果已在Cell …See details»
Turning the immune system on cancer and lung disease - Nature
Although surgery, chemotherapy and radiation remain the mainstay of most cancer treatments, there is also another powerful tool: a patient’s own immune system. Since the 1990s, immune …See details»
清辉联诺完成 1 亿元 Pre-A 轮融资，加速开发实体肿瘤创新疗法
11月22日，北京清辉联诺生物科技有限责任公司（以下简称“清辉联诺”）宣布完成1亿元人民币Pre-A轮融资。本轮融资由中关村协同创新基金、龙磐投资、弘晖资本共同出资，资金将用于公司 …See details»
-unicet Biotech - Products, Competitors, Financials, Employees ...
CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve …See details»
允思拓 – 思大道于微观，拓科学之疆界
允思拓的核心团队在生物信息分析领域深耕10年以上，积累了丰富的分析和开发经验。我们坚持紧跟科研趋势，不断创新，为科研工作者提供最具影响力的科学成果和技术洞察。See details»
Unicyte Company Profile - Office Locations, Competitors ... - Craft
Unicyte is a regenerative medicine company developing targeted therapeutics using stem cell technologies. It focuses on kidney or liver disease, diabetes, and cancer utilizing its major …See details»
Company Profile - Uniten Bio
Uniten is a global leader in the development of novel biomarker technology platforms focused on metabolic immunodiagnostic products. Relying on the team of the State Key Laboratory of …See details»
OmniaBio: Positioning Ontario to lead in a global …
Apr 26, 2023 In September 2022, the industry-led organization behind Canada’s Global Innovation Cluster for Advanced Manufacturing announced it had made a $10.5 million …See details»
Nicola-Aceto - The Aceto Lab
Nicola Aceto is Full Professor of Molecular Oncology at the ETH Zurich. Prior to joining ETH, he has been Swiss National Science Foundation Assistant Professor of Oncology at the …See details»
Biotechnology Innovation Organization | BIO
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services.See details»
OMNIABIO: POSITIONING ONTARIO TO LEAD IN A GLOBAL
May 4, 2023 In September 2022, the industry-led organization behind Canada’s Global Innovation Cluster for Advanced Manufacturing announced it had made a $10.5 million …See details»
Meet Mitch: The CEO leading Canada’s largest CDMO dedicated to ...
Sep 15, 2022 The new contract development and manufacturing organization (CDMO) will focus on producing gene-modified cell therapies and viral vectors compliant with Good …See details»
Ngen supports commercial scale manufacturing of cell and
Sep 20, 2022 NGen is the industry-led not-for-profit organization that leads Canada’s Global Innovation Cluster for Advanced Manufacturing. Its mandate is to help build world-leading …See details»
OmniaBio’s Impact and Future with Mitchel Sivilotti
Apr 27, 2024 Mitch Sivilotti, CEO of OmniaBio Inc., shared with CanadianSME Small Business Magazine how OmniaBio is propelling Canada to the forefront of cell and gene therapy (CGT) …See details»
Home - Biomedit
BiomEdit is an innovation company that discovers, designs, and develops novel microbiome-derived products to address unmet needs in animal health.See details»